2021
DOI: 10.3390/biology10100964
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of Albumin ECM Accumulation and Inflammation as Novel In Vivo Diagnostic Targets for Multi-Target MR Imaging

Abstract: Atherosclerosis is a progressive inflammatory vascular disease characterized by endothelial dysfunction and plaque burden. Extracellular matrix (ECM)-associated plasma proteins play an important role in disease development. Our magnetic resonance imaging (MRI) study investigates the feasibility of using two different molecular MRI probes for the simultaneous assessment of ECM-associated intraplaque albumin deposits caused by endothelial damage and progressive inflammation in atherosclerosis. Male apolipoprotei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 40 publications
0
3
0
Order By: Relevance
“…Thus, it can be said that macrophages are able to take up ferumoxytol. We have already been able to show this in other diseases [ 21 , 22 , 23 ]. Some publications indicate that tumor-associated macrophages (TAMs) are able to take up administered nanoparticles [ 24 , 25 ].…”
Section: Discussionmentioning
confidence: 75%
See 1 more Smart Citation
“…Thus, it can be said that macrophages are able to take up ferumoxytol. We have already been able to show this in other diseases [ 21 , 22 , 23 ]. Some publications indicate that tumor-associated macrophages (TAMs) are able to take up administered nanoparticles [ 24 , 25 ].…”
Section: Discussionmentioning
confidence: 75%
“…Ferumoxytol is not only used in imaging techniques for tumor diseases but may also have applications in cardiovascular diseases [ 21 , 22 , 44 ] and the central nervous system [ 15 ]. Different studies have investigated the molecular properties of cardiovascular disease with a combined approach using iron-oxide nanoparticles and a gadolinium-based contrast agent [ 21 , 22 , 44 ]. A limitation that needs to be considered regarding ferumoxytol is that it is not prostate tumor specific or even tumor specific.…”
Section: Discussionmentioning
confidence: 99%
“…It would be highly interesting to study whether the design of EPI-X4 derivatives containing thiol-reactive linkers may allow albumin binding after systemic administration of the peptide. The circulating albumin preferentially accumulates in tumors [ 31 ] or inflamed tissues [ 32 , 33 ], delivering optimized EPI-X4 molecules to the sites where they are therapeutically required.…”
Section: Discussionmentioning
confidence: 99%